ArticleRegenerative therapy2020

The combination of dibenzazepine and a DOT1L inhibitor enables a stable maintenance of human naïve-state pluripotency in non-hypoxic conditions.

Wataru Isono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.